Orphan Drug Designation Granted By FDA For This Medical Tech Company
FDA Grants Orphan Drug Designation to Creative Medical Technology's CELZ-101: A Major Breakthrough in Transplantation Therapy.
In a significant development that could potentially revolutionize transplantation therapy, Creative Medical Technology Holdings, Inc. has received the FDA's Orphan Drug Designation for its innovative drug, CELZ-101. This breakthrough holds the promise of improving the lives of many patients who rely on transplantation therapy. $Creative Medical Technology(CELZ.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
hard-working Camel_4 : fly soon